Treatment access varies dramatically by geography. According to SAMHSA's 2023 National Survey, states like California, Florida, New York, and Pennsylvania have the highest concentration of treatment facilities — but even within these states, rural counties often have zero providers within a 30-mile radius.
The opioid crisis has driven expansion of medication-assisted treatment (MAT) in many states. As of 2024, over 2,000 Opioid Treatment Programs (OTPs) operate nationally. States that expanded Medicaid under the ACA report 20–30% higher treatment utilization rates than non-expansion states (Kaiser Family Foundation, 2023). Read our guide on paying for rehab without insurance for details on Medicaid eligibility.
What Are the Key Trends by Region?
- California leads nationally with the most treatment facilities. California was among the first states to mandate insurance parity for addiction treatment.
- Florida has become a major destination for residential treatment, particularly in the South Florida corridor. The state implemented the Marchman Act for involuntary assessment.
- Ohio and West Virginia have expanded MAT access in response to the fentanyl crisis, with Quick Response Teams deploying within 72 hours of overdose events.
- Rural states increasingly rely on telehealth-based treatment. DEA's expanded telehealth rules allow buprenorphine initiation via video call.
Select a state above or use our facility search to filter by detox, inpatient, or outpatient. For job-protection during treatment, read our FMLA guide.
The Medicaid Expansion Impact on Treatment Access
Medicaid Expansion under the Affordable Care Act has become the single biggest determinant of rehab access at the state level. As of 2026, 41 states plus D.C. have expanded Medicaid, meaning any adult earning up to 138% of the federal poverty level (~$20,800 for a single adult) qualifies regardless of employment or disability status. The 10 non-expansion states — Alabama, Florida, Georgia, Kansas, Mississippi, South Carolina, Tennessee, Texas, Wisconsin, Wyoming — leave an estimated 2.1 million Americans in the "coverage gap": too poor for ACA marketplace subsidies, too wealthy for traditional Medicaid.
Kaiser Family Foundation data (2023) shows the treatment-utilization gap is measurable. In Ohio, expansion-state residents are 2.4× more likely to receive medication-assisted treatment for opioid use disorder than residents of neighboring non-expansion Kentucky counties before their 2014 expansion. Research from JAMA Network Open (Saloner et al., 2022) found that Medicaid Expansion reduced opioid overdose death rates by 11–12% in expansion states within three years of implementation — largely through increased MAT access.
The 2018 SUPPORT Act further strengthened Medicaid SUD coverage by allowing states to waive the Institutions for Mental Diseases (IMD) exclusion. As of 2026, 40+ states hold IMD waivers — meaning Medicaid can pay for residential treatment in facilities with 17 or more beds, something previously excluded. If you're in a non-expansion state, our no-insurance paying guide covers SAMHSA block-grant programs and sliding-scale options that remain available.
Most Common Treatment Types by Region
Regional drug use patterns drive regional treatment mix. The SAMHSA 2023 N-SSATS facility census shows meaningful divergence in what's available where:
- Northeast (ME, VT, NH, MA, CT, RI, NY, NJ, PA): highest per-capita concentration of MAT programs, reflecting decades of heroin-then-fentanyl crisis. Massachusetts alone has more buprenorphine prescribers per 10,000 population than any state. Philadelphia, New York City, and Boston also lead in dual-diagnosis treatment for serious mental illness with co-occurring SUD.
- Southeast (FL, GA, NC, SC, VA, TN, AL, MS, LA): dominant market for residential/inpatient care, especially in South Florida's "treatment corridor" (Palm Beach County alone has more residential beds than most midwestern states). Downsides: highest concentration of poorly-regulated operators per GAO reports — always verify SAMHSA listing and accreditation.
- Midwest (OH, IN, IL, MI, WI, MN, IA, MO, KS): balanced mix, with Ohio leading MAT expansion in response to fentanyl. Rural Midwest relies increasingly on telehealth — Indiana and Wisconsin have among the highest per-capita telehealth SUD visits (DEA data, 2024).
- Mountain West + Southwest (CO, UT, AZ, NM, NV, MT, WY, ID): strong in outpatient and IOP networks tied to academic medical centers. Arizona and Utah have active sober-living ecosystems regulated by AzRHA and state licensing respectively. Native American reservations have IHS-funded SUD programs with unique cultural frameworks.
- Pacific (CA, OR, WA, AK, HI): California has the most facilities nationally; Oregon decriminalized personal drug possession in 2021 (since modified in 2024) and invested heavily in harm-reduction-integrated treatment. Washington state leads in co-occurring trauma-informed care.
Rural vs Urban Treatment Access
The rural-urban treatment gap is one of the most persistent structural problems in U.S. addiction care. Roughly 46 million Americans live in counties SAMHSA classifies as "SUD provider shortage areas" — counties with fewer than 1 buprenorphine prescriber per 10,000 residents. Most are rural: Nebraska, Iowa, Montana, Mississippi, and parts of Appalachia account for the densest clusters of untreated SUD.
Three structural barriers drive the gap:
- Provider density. Rural counties average 0.6 board-certified addiction specialists per 10,000 population vs. 3.1 in urban counties (Health Affairs, 2022). For residential care, rural residents often travel 60+ miles one-way — a significant barrier for families and employer-flexibility.
- Transportation. Public transit is rarely viable; car ownership and gas costs become clinical factors. Medicaid's Non-Emergency Medical Transportation benefit helps but is underutilized (~8% of eligible rural Medicaid members use it for SUD appointments).
- Privacy concerns. In small towns, seeing a neighbor's car at the SUD clinic is a real deterrent. This is one reason telehealth-based MAT has outperformed in-person care in rural areas since 2020.
Two developments have narrowed the gap since 2020. First, the DEA's expanded telehealth prescribing rules (extended through 2025) allow buprenorphine initiation over video call — a quiet revolution that removed the in-person visit requirement. Second, Project ECHO programs at academic medical centers (University of New Mexico, University of Washington, Vanderbilt) train rural primary-care physicians to prescribe MAT, multiplying effective provider capacity. If you're in a rural county, our telehealth facility filter is often the fastest path to same-week intake.
State-Specific Resources Every Family Should Know
Beyond facility directories, every state maintains resources that can accelerate access to treatment — most of them underutilized. If you're navigating a crisis, these are the most useful layers beyond calling a specific rehab:
- State SUD hotlines. Separate from the federal SAMHSA line (1-800-662-HELP). Most states run their own 24/7 hotline staffed by clinicians who know the state's specific landscape — Medicaid rules, open-bed availability at state-funded facilities, and which counties have same-week intake. New York's OASAS HOPEline, Massachusetts's Helpline, Ohio's Recovery Ohio, and Pennsylvania's Get Help Now line are particularly well-resourced.
- Single State Agencies (SSAs). Every state has a designated agency that administers SAMHSA block grants — federal funding that subsidizes treatment for uninsured residents. In most states, the SSA maintains a priority-access list for pregnant women, injection drug users, and individuals with dependent children. Contact your SSA (directory at samhsa.gov) for priority referrals.
- 988 Suicide and Crisis Lifeline. Launched July 2022 as the nationwide crisis line replacing the old 10-digit number. 988 handles both suicidal and SUD crises and is routed to your state's crisis-response infrastructure. Many states have built mobile crisis teams that respond in person within 60 minutes.
- County Behavioral Health Authorities (BHAs). County-level offices that coordinate public mental health and SUD services. If you're uninsured or underinsured, your county BHA can often arrange same-day assessment and place you on a priority waitlist for state-funded residential — frequently faster than searching private facilities.
- Needle exchange and harm reduction programs. In most states, harm reduction programs function as a low-threshold on-ramp to treatment. Many people who weren't ready for abstinence accept a MAT referral from the outreach worker who gave them naloxone. NEXT Distro, Vital Strategies, and state-funded programs in NY, CA, MA, and NM are among the most active.
- Family support programs. Al-Anon, Nar-Anon, and SMART Recovery Family & Friends operate in every state. For navigating the first 30 days of a loved one's treatment, these peer groups are often more useful than professional therapy. Our family therapy guide covers when to bring a professional into the mix.
- Drug courts. If the person struggling with SUD is facing charges, over 3,000 drug courts nationally offer treatment-in-lieu-of-incarceration. Drug court graduates show 12–15% lower re-arrest rates than traditional probation per the National Association of Drug Court Professionals — and they often include intensive SUD treatment that would otherwise be unaffordable.
If you're overwhelmed by the options, the simplest starting point is still calling your state's SSA-run hotline. They triage based on urgency, insurance status, and medical complexity, then route you to the appropriate next step — often something you wouldn't have found on your own.